Angiotensin II receptor antagonist reduces urinary liver-type fatty acid-binding protein levels in patients with diabetic nephropathy and chronic renal failure.

Diabetologia

Volumn 50, Issue 2, 2007, Pages 490-492

  Nakamura, T ^a   Sugaya, T ^b   Koide, H ^c  

^a Shinmatsudo Central General Hospital   (Japan)

^b RIKEN KOBE INSTITUTE   (Japan)

^c KOTO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FATTY ACID BINDING PROTEIN; TELMISARTAN;

BLOOD; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; DRUG ANTAGONISM; GLOMERULUS FILTRATION RATE; HUMAN; LETTER; URINE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENZIMIDAZOLES; BENZOATES; CREATININE; DIABETIC NEPHROPATHIES; FATTY ACID-BINDING PROTEINS; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; RECEPTORS, ANGIOTENSIN;

EID: 34648828993     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0545-4     Document Type: Letter

References (0)